Manufacturers Life Insurance Company, The Maxcyte, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Maxcyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 41,037 shares of MXCT stock, worth $140,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,037
Previous 42,289
2.96%
Holding current value
$140,346
Previous $165,000
3.64%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
65.6MCall Options Held
1KPut Options Held
2K-
Cadian Capital Management, LP New York, NY8.19MShares$28 Million1.63% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$27.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.78MShares$19.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$17.2 Million7.62% of portfolio
-
Morgan Stanley New York, NY4.82MShares$16.5 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $348M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...